Home / Stocks / FDS

FactSet Research Systems (FDS, Financial Exchanges & Data) Stock Valuation & Fair Value Favorable on our tests

FactSet Research Systems (FDS, Financial Exchanges & Data) trades at a blended P/E of 14.7, about 44% below its historical normal valuation, with a forward growth estimate of 9.8% and a PEG of 1.49. Analysts' one-year estimates have been hit 91% of the time. Priced at its historical normal P/E of 26.0 on the same blended earnings, the 2026-10-02 close of $266.00 corresponds to about $471 a share. This is a valuation reference, not a price target.

Blended P/E
14.7
Normal P/E
26.0
PEG
1.49
Fwd growth
9.8%
Div yield
1.7%
RSI (14)
55.2
Neutral
Technical context
  • Price $286.52 at the 2026-10-08 close, 4.5% above the 20-day average ($274.30) and 1.4% above the 50-day ($282.57).
  • RSI (14) at 55.2.
  • 52-week range $187.46 to $313.55: the price is 8.6% below the high and 52.8% above the low.
  • At its last earnings report the options market priced a 6.5% move.

The Street vs SeerForecast

Wall Street's mean price target for FDS is $277.56 across 16 analysts, 3.1% below the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: favorable on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been favorable on our tests since 2026-06-03.

Blended P/E and rating by weekBlended P/E moved from 13.6 to 14.7 between 2026-06-03 and 2026-10-02, against a normal P/E of 26.3, with 2 rating changes over 37 recorded weeks.2026-06-03: P/E 13.6, Favorable on our tests, recalculated for the week of 2026-06-032026-06-10: P/E 14.6, Favorable on our tests, recalculated for the week of 2026-06-102026-06-12: P/E 14.6, Favorable on our tests, recalculated for the week of 2026-06-142026-06-16: P/E 14.6, Favorable on our tests, recalculated for the week of 2026-06-162026-06-18: P/E 14.6, Favorable on our tests, recalculated for the week of 2026-06-212026-07-02: P/E 13.9, Favorable on our tests, recalculated for the week of 2026-07-022026-07-06: P/E 14.1, Favorable on our tests, recalculated for the week of 2026-07-062026-07-09: P/E 14.1, Favorable on our tests, recalculated for the week of 2026-07-092026-07-10: P/E 14.0, Favorable on our tests, recalculated for the week of 2026-07-122026-07-13: P/E 14.0, Favorable on our tests, recalculated for the week of 2026-07-132026-07-14: P/E 14.0, Favorable on our tests, recalculated for the week of 2026-07-142026-07-20: P/E 14.6, Favorable on our tests, recalculated for the week of 2026-07-202026-07-22: P/E 14.6, Favorable on our tests, recalculated for the week of 2026-07-222026-07-24: P/E 14.3, Favorable on our tests, recalculated for the week of 2026-07-252026-07-27: P/E 14.3, Favorable on our tests, recalculated for the week of 2026-07-272026-07-31: P/E 14.8, Favorable on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 14.8, Favorable on our tests, recorded live 2026-08-032026-08-07: P/E 15.4, Favorable on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 16.1, Mixed on our tests, recorded live 2026-08-102026-08-14: P/E 16.1, Mixed on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 15.9, Mixed on our tests, recorded live 2026-08-172026-08-21: P/E 16.9, Mixed on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 16.8, Mixed on our tests, recorded live 2026-08-242026-08-27: P/E 16.8, Mixed on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 17.1, Mixed on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 17.3, Mixed on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 17.3, Mixed on our tests, recorded live 2026-08-312026-09-04: P/E 16.9, Mixed on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 16.9, Mixed on our tests, recorded live 2026-09-072026-09-11: P/E 14.5, Favorable on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 14.5, Favorable on our tests, recorded live 2026-09-142026-09-18: P/E 15.8, Favorable on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 15.8, Favorable on our tests, recorded live 2026-09-212026-09-25: P/E 15.2, Favorable on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 15.2, Favorable on our tests, recorded live 2026-09-282026-10-02: P/E 14.7, Favorable on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 14.7, Favorable on our tests, recorded live 2026-10-0515.020.025.0Jun 3Jul 3Aug 2Sep 2Oct 2Normal P/E 26.3
Favorable on our testsMixed on our tests

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 13.6-48%Favorable on our tests (recalculated)
2026-08-10P/E 16.1-39%Mixed on our tests
2026-08-30P/E 17.3-34%Mixed on our tests (recalculated)
2026-09-12P/E 14.5-45%Favorable on our tests (recalculated)
2026-10-05P/E 14.7-44%Favorable on our tests ← now
Show all 37 weeks
WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 13.6-48%Favorable on our tests (recalculated)
2026-06-10P/E 14.6-45%Favorable on our tests (recalculated)
2026-06-14P/E 14.6-45%Favorable on our tests (recalculated)
2026-06-16P/E 14.6-45%Favorable on our tests (recalculated)
2026-06-21P/E 14.6-45%Favorable on our tests (recalculated)
2026-07-02P/E 13.9-47%Favorable on our tests (recalculated)
2026-07-06P/E 14.1-46%Favorable on our tests (recalculated)
2026-07-09P/E 14.1-46%Favorable on our tests (recalculated)
2026-07-12P/E 14.0-47%Favorable on our tests (recalculated)
2026-07-13P/E 14.0-47%Favorable on our tests (recalculated)
2026-07-14P/E 14.0-47%Favorable on our tests (recalculated)
2026-07-20P/E 14.6-45%Favorable on our tests (recalculated)
2026-07-22P/E 14.6-45%Favorable on our tests (recalculated)
2026-07-25P/E 14.3-45%Favorable on our tests (recalculated)
2026-07-27P/E 14.3-45%Favorable on our tests (recalculated)
2026-07-31P/E 14.8-44%Favorable on our tests (recalculated)
2026-08-03P/E 14.8-44%Favorable on our tests
2026-08-07P/E 15.4-41%Favorable on our tests (recalculated)
2026-08-10P/E 16.1-39%Mixed on our tests
2026-08-14P/E 16.1-39%Mixed on our tests (recalculated)
2026-08-17P/E 15.9-39%Mixed on our tests
2026-08-21P/E 16.9-36%Mixed on our tests (recalculated)
2026-08-24P/E 16.8-36%Mixed on our tests
2026-08-27P/E 16.8-36%Mixed on our tests (recalculated)
2026-08-28P/E 17.1-35%Mixed on our tests (recalculated)
2026-08-30P/E 17.3-34%Mixed on our tests (recalculated)
2026-08-31P/E 17.3-34%Mixed on our tests
2026-09-05P/E 16.9-36%Mixed on our tests (recalculated)
2026-09-07P/E 16.9-36%Mixed on our tests
2026-09-12P/E 14.5-45%Favorable on our tests (recalculated)
2026-09-14P/E 14.5-45%Favorable on our tests
2026-09-19P/E 15.8-40%Favorable on our tests (recalculated)
2026-09-21P/E 15.8-40%Favorable on our tests
2026-09-26P/E 15.2-42%Favorable on our tests (recalculated)
2026-09-28P/E 15.2-42%Favorable on our tests
2026-10-03P/E 14.7-44%Favorable on our tests (recalculated)
2026-10-05P/E 14.7-44%Favorable on our tests ← now

Earnings moves: FDS moved more than the options market implied in 0 of 1 recent tracked reports.

Frequently asked questions

Is FactSet Research Systems stock overvalued?

At a blended P/E of 14.7 versus its historical normal P/E of 26.0, FactSet Research Systems trades about 44% below its typical valuation, with a PEG of 1.49 on 9.8% forward growth. tickerseer currently rates it favorable on our tests.

What is FactSet Research Systems's fair value and PEG?

FactSet Research Systems trades at a blended P/E of 14.7 against a historical normal P/E of 26.0, a PEG of 1.49, and a forward growth estimate of 9.8%. Priced at its historical normal P/E of 26.0 on the same blended earnings, the 2026-10-02 close of $266.00 corresponds to about $471 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of FactSet Research Systems changed?

tickerseer's rating has been favorable on our tests since 2026-06-03.

What is the analyst price target for FactSet Research Systems?

The mean Wall Street price target for FactSet Research Systems is $277.56 across 16 analysts, 3.1% below the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Financial Exchanges & Data. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.